In addition to IFN-β or TRAIL, there are several other tumor-suppressor genes and cytokines with anticancer activities, such as CXCL10 [29], IL-12 [30], and pigment epithelium-derived factor (PEDF) [31], which are utilized for the genetic modification of ADSCs. The gene discussed is CXCL10; the disease is neoplasm.